Down-regulation of VLDL receptor expression in chronic experimental renal failure

Kidney International

Volumn 51, Issue 3, 1997, Pages 913-919

  Vaziri, Nosratola D ^a,b   Liang, Kaihui ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

EID: 0030934687     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.129     Document Type: Article

References (36)

1. ATTMAN PO, SAMUELSON O, ALAUPOVIC P: Lipoprotein metabolism in renal failure. Am J Kidney Dis 21:573-592, 1993
2. CHAN MK, VARGHESE Z, MOORHEAD JF: Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int 19:625-637, 1981
3. HAHN R, OETTE K, MONDORF H, FINKE K, SIEBERTH HG: Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 48: 279-288, 1983
4. HORKKO S, HUTTUNEN K, KORHONEN T, KESANIEMI YA: Decreased clearance of low-density lipoprotein in patients with chronic renal failure. Kidney Int 45:561-570, 1994
5. WEINTRAUB M, BURSTEIN A, RASSIN T, LIRON M, RINGEL Y, CABILI S, BLUM M, PEER G, IANA A: Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int 42:1247-1252, 1992
6. ATTMAN PO, GUSTAFSON A: Lipid and carbohydrate metabolism in uraemia. Eur J Physiol 9:285-291, 1979
7. GOLDBERG A, SHERRARD DJ, BRUNZELL JD: Adipose tissue lipoprotein lipase in chronic hemodialysis: Role in plasma triglyceride metabolism. J Clin Endocrinol Metab 47:1173-1182, 1978
8. AKMAL M, KASIM SE, SOLIMAN AR, MASSRY SG: Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 37:854-858, 1990
9. ROULLET JB, LACOUR B, YVERT JP, PRAT JJ, DRUEKE T: Factors of increase in serum triglyceride-rich lipoprotein in uremic rats. Kidney Int 27:420-425, 1985
10. SHOJI T, NISHIZAWA Y, NISHITANI H, YAMAKAWA M, MORII H: Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int 41:1653-1661, 1992
11. SAKURAI T, OKA T, HASEGAWA H, IGAKI N, MIKI S, GOTO T: Comparison of lipids, apolipoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease. Nephron 61:409-414, 1992
12. CHAN MK, PERSAUD J, VARGHESE Z, MOORHEAD JF: Pathogenic role of post-heparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 25:812-818, 1984
13. MURASE T, CATTRAN DC, RUBENSTEIN B, STEINER G: Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metabolism 24:1229-1286, 1975
14. CRAWFORD GA, MAHONY JF, STEWART JH: Impaired lipoprotein lipase activation by uraemic and post-transplant sera. Clin Sci 60:73-80, 1981
15. SERES DS, STRAIN GW, HASHIM SA, GOLDBERG IJ, LEVIN NW: Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 3:1409-1415, 1993
16. CHEUNG AK, PARKER CJ, REN K, IVERIUS PH: Increased lipase inhibition in uremia: Identification of pre-β-HDL as a major inhibitor in normal and uremic plasma. Kidney Int 49:1360-1371, 1996
17. VAZIRI ND, LIANG KH: Down regulation of tissue lipoprotein lipase in experimental chronic renal failure. Kidney Int 50:1928-1935, 1996
18. TAKAHASHI S, KAWARABAYASI Y, NAKAI T, SAKAI J, YAMAMOTO T: Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89:9252-9256, 1992
19. SUDHOF TC, GOLDSTEIN JL, BROWN MS, RUSSELL DW: The LDL receptor gene: A mosaic of exons shared with different proteins. Science 228:815-822, 1985
20. GOLDSTEIN JL, BROWN MS: The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 46:897-930, 1977
21. SAKAI J, HOSHINO A, TAKAHASHI S, MIURA Y, ISHII H, SUSUKI H, KAWARABAYASI Y, YAMAMOTO T: Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J Bio Chem 269:2173-2182, 1994
22. OKA K, TZUNG KW, SULLIVAN M, LINDSAY E, BALDINI A, CHAN L: Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization. Genomics 20:298-300, 1994
23. WEBB JC, PATEL DD, JONES MD, KNIGHT BL, SOUTAR AK: Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA. Hum Mol Gen 3:531-537, 1994
24. GAFVELS ME, CAIRD M, BRITT D, JACKSON CL, PATTERSON D, STRAUSS JF: Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23. Somatic Cell Mol Genet 19:557-569, 1993
25. AUWERK J, LEROY P, SCHOONJANS K: Lipoprotein lipase: Recent contributions from molecular biology. Crit Rev Clin Lab Sci 29:243-268, 1992
26. POLLOCK CA, WYNDHAM R, COLLETT PV, ELDER G, FIELD MJ, KALOWSKI S, LAWRENCE JR, WAGH DA, GEORGE CRP: Effects of erythropoietin therapy on the lipid profile in end-stage renal failure. Kidney Int 45:897-902, 1994
27. VAZIRI ND, ZHOU XJ, NAQVI F, SMITH J, OVEISI F, WANG ZQ, PURDY RE: Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am J Physiol (Endocrinol Metab) 23:E113-E123, 1996
28. JOKINEN EV, LANDSCHULZ KT, WYNE KL, HO YK, FRYKMAN PK, HOBBS HH: Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J Biol Chem 269:26411-26418, 1994
29. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid-guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
30. JOVEN J, VILELLA E, AHMAD S, CHEUNG MC, BRUNZELL JD: Lipoprotein heterogeneity in end-stage renal disease. Kidney Int 43:410-418, 1993
31. NESTEL PJ, FIDGE NH, TAN MH: Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 307:329-333, 1982
32. HEUCK CC, LIERSCH M, RITZ E, STEGMEIR K, WIRTH A, MEHLS O: Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat. Kidney Int 14:142-150, 1978
33. LIANG K, VAZIRI ND: Depressed expression of VLDL receptor protein in experimental nephrosis. (manuscript in preparation)
34. VAZIRI ND, LIANG K: Hepatic HMG-CoA reductase gene expression in the course of puromycin-induced nephrosis. Kidney Int 48:1979-1985, 1995
35. TIAN J, SMOGORZEWSKI M, KEDES L, MASSRY SG: PTH-PTHrP receptor mRNA is down regulated in chronic renal failure. Am J Nephrol 14:41-46, 1994
36. KLIN M, SMOGORZEWSKI M, NI Z, ZHANG G, MASSRY SG: Abnormalities in hepatic lipase in chronic renal failure: Role of excess parathyroid hormone. J Clin Invest 97:2167-2173, 1996